哈密海绵体损伤怎么恢复-【哈密博爱医院】,哈密博爱医院,哈密坐包皮手术多少钱,哈密治疗阳痿做手术多少钱,哈密那家的妇科医院,哈密好的男科病医院,哈密男性男性前列腺炎医院,哈密女性的妇科检查医院哪家好
哈密海绵体损伤怎么恢复哈密早孕测试纸一深一浅,哈密哪家治妇科的医院好,哈密割包皮一般要多少岁,哈密做包皮手术当天能出院吗,哈密男子精液常规检查,哈密市治疗妇科的医院,哈密做包皮手术当天能出院吗
(KGTV) — Stark similarities between a San Francisco brewery's beer can and the iconic soft drink cups used at In-N-Out prompted the burger chain to issue a cease and desist letter, though not without some light-hearted humor.Seven Stills Brewing recently crafted a new Neapolitan-style beer called "In-N-Stout," wrapped in a design resembling the much-loved burger chain's cup featuring palm trees and its signature yellow arrow.The resemblance is uncanny. So much so that it forced the burger chain to respond with a letter, politely asking the brewery to ditch the can.RELATED: In-N-Out sues Smashburger over new 'Triple-Double' burgerThe brewery posted the pun-laden letter on Instagram, with the caption, "We count 9. Can you find them all?""Based on your use of our marks, we felt obligated to hop to action in order to prevent further issues from brewing," In-N-Out wrote. "We hope you appreciate, however, that we are attempting to clearly distill our rights by crafting an amicable approach with you, rather than barrel through this."We look forward to resolving this in good spirits," the letter ends.RELATED: In-N-Out continues customer loyalty winning streakThe brewery has since said they will repackage?the beer, though it will remain a Neapolitan-flavored stout. They'll also be serving In-N-Out to the first 100 guests on release day. 1388
(KGTV) - Do the recent California wildfires line up with the route of the proposed high-speed rail?No.The implication is the fires were intentionally set to clear the land for the rail line.But the two maps being compared to each other are inaccurate and misrepresented. 293
(KGTV) - Does a picture being sent around online show a real 2-headed shark?No, but they do exist in nature.Marine biologists have discovered a number of 2-headed shark embryos.Possible causes include pollution, viral infections, and inbreeding caused by overfishing. 280
(KGTV) -- Many scientists and doctors are cautiously optimistic about taking a step forward in the fight against COVID-19 after encouraging news from Pfizer Monday.Pfizer announced that early data revealed its vaccine was more than 90 percent effective in protecting trial participants against the coronavirus.The U.S. Federal Food and Drug Admiration still needs to review the drug for safety and efficacy, and Pfizer plans to seek an Emergency Use Authorization this month, but regardless some see this as a good sign for other vaccine trials.“I think this is frankly the break we’ve all been waiting for, and I hope we have many others to follow,” said Dr. Susan Little, a UC San Diego Professor of Medicine.UCSD is participating in Phase 3 clinical trials for Moderna, AstraZeneca, and Janssen vaccines.Little leads the AstraZeneca and Janssen trials, which resumed locally last week.“I think what this means for all of the trials that are available at this stage, this is incredibly good news,” she said. “So far, they all use the same approach to vaccine development; they are all targeting the same protein, the spike protein, on the coronavirus.”She expects similar results to come from Moderna’s early data sometime this year.“The Pfizer and the Moderna both use the same vaccine platform, the same structure for their vaccine construct, so there’s every reason to be very optimistic the Moderna study might show similar results,” she said. “While the AstraZeneca and the Janssen use a different vaccine construct, they both are targeting the same protein.”If Pfizer’s vaccine is approved, it could be given to healthcare workers and high-risk populations in just months, and the general population in 2021, according to Pfizer.Pfizer said it expects to produce 50 million vaccine doses globally in 2020 and up to 1.3 billion in 2021.Pfizer’s CEO, Albert Bourla, said he expects the vaccine to be free of charge for Americans. 1943
(KGTV) One of the biggest city-owned office spaces sits vacant and may do so for a little while longer.The City of San Diego acquired the 19-story tower at 101 Ash St. in the beginning of last year in effort to consolidate staff into a new space, but various delays have kept the renovation from being completed.Officials signed a lease-to-own contract for the old Sempra Energy building and have been paying more 5,000 a month plus operational costs since January of 2017.The city was supposed to move in July 2017 and the estimated daily cost for the vacant structure is a little less than ,000.“I do believe the city has bungled this decision from the beginning starting with the purchase,” said San Diego City Councilmember Barbara Bry.Bry was elected to council after officials voted to acquire the building for million and says the issue can be traced to how city staff briefed council just before the purchase.“At the time city staff told the council that the building was in excellent shape and the million in tenant improvements was enough,” added Bry.Records indicate the city has paid more than million in rent and roughly million in operating costs since taking over the property.Bry is working behind the scenes to mitigate the matter before the costs balloon any more, but estimates it will be at least six months until staff can move into the 101 Ash Street building.The City of San Diego says more than 1,100 employees will work there when the renovation is complete and they plan to move into the building sometime in fiscal year 2019 — which begins in July. 1617